NCT07065721 Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
| NCT ID | NCT07065721 |
| Status | Recruiting |
| Phase | — |
| Sponsor | San Diego State University |
| Condition | Type 2 Diabetes Mellitus (T2DM) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-10-02 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-10-02 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.
Eligibility Criteria
Inclusion Criteria: * adult 18-45 years of age * diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record * no prior use or experience with wearable CGMs * possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize the Dexcom CGM app * fluency in English or Spanish Exclusion Criteria: * severe mental illness (e.g., psychosis, suicidal ideation); * pregnancy or \<6 months postpartum
Contact & Investigator
Jessica L McCurley, PhD MPH
PRINCIPAL INVESTIGATOR
San Diego State University
Frequently Asked Questions
Who can join the NCT07065721 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Type 2 Diabetes Mellitus (T2DM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07065721 currently recruiting?
Yes, NCT07065721 is actively recruiting participants. Contact the research team at jlmccurley@sdsu.edu for enrollment information.
Where is the NCT07065721 trial being conducted?
This trial is being conducted at San Diego, United States.
Who is sponsoring the NCT07065721 clinical trial?
NCT07065721 is sponsored by San Diego State University. The principal investigator is Jessica L McCurley, PhD MPH at San Diego State University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.